Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Identity fraud reached a critical point in 2025. Insights from Regula’s analysis of the identity fraud data reveal the risks and trends emerging in 2026.
Read More -
Manny Alvarez Achieved a 77.14% Win Rate for Clients in 2025 Mr. Alvarez’s Bilingual Talent Helped Secure Victories for 27 out of 35 Campaign Clients that Implemented GOTV’s Voter Turnout Plan ...
Read More
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
-
Cergy, France, 15 December 2025 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the signing of a European framework agreement...
-
Announcement A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back programOn 5 February 2025, A.P. Møller - Mærsk A/S (the “Company”) announced a share buy-back program of up to...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
Burlingame, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Global Care Management Solutions Market is estimated to be valued at USD 16.66 Bn in 2025 and is expected to reach USD 43.80 Bn by...
-
The patent reinforces Rail Vision’s global IP protection building on previous approvals in regions including the United States, Japan, and India Ra’anana, Israel, Dec. 15, 2025 (GLOBE NEWSWIRE) --...
-
NEW BRUNSWICK, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”) today announced the completion of the sale of its approximately 34% ownership interest...
-
PHILADELPHIA, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Alexandria Real Estate Equities, Inc. (NYSE: ARE): Grabar Law Office is investigating claims on behalf of shareholders of Alexandria Real...
-
PharmAla ships MDMA to Mt. Sinai Hospital and starts making patented novel MDMA-like drug, preparing for a phase 2 clinical trial into Social Anxiety.
-
IPERIONX AND CARVER PUMP TO ACCELERATE CRITICAL COMPONENT PRODUCTION FOR U.S. NAVY SHIPS